MAR COR Purification Announces Award of Health Canada License
New Design Features Energy Conservation and Fully Automated Hot Water Disinfection
Plymouth, MN– Mar Cor Purification announced today that it has been awarded a Class 3 Device License from Health Canada for a Heat Disinfectable Centralized Reverse Osmosis (RO) Water System for Dialysis, named the BioPure HX2. The BioPure HX2 is a Double Pass RO with automatic hot water disinfection with 4 different modes. It is designed to produce high quality water and distribution for large capacity applications up to 50 stations and/or 1,000 foot loop lengths. An added feature to the design is the ability to operate either as a double pass RO or as a single RO in the event of any issues with either pass. In order to reduce the carbon footprint of the system, the system is outfitted with VFD drives and automatic adjustment of product flow and reject flow based on demand and feed water quality, conserving water and energy. The system will be manufactured in the Mar Cor ISO 13485/CMDCAS registered factory in Burlington, Ontario and conforms to various standards including but not limited to: CAN/CSA C22.2#61010-1 Standard for Electrical Safety and IEC 61326-1 Electrical Emissions-General Requirements.
John Rickert, VP Medical Sales, commented, "The BioPure HX is a next generation, state of the art RO and Distribution system, that will meet and exceed the stringent requirements for dialysis and hemodiafiltration water treatment, anywhere in the world. The BioPure HX2 is designed to install quickly, incorporate energy recovery technologies, automatically heat disinfect the entire system, and employs sophisticated hydraulic & pneumatic controls to automatically adjust critical parameters to optimize the system operation. This device will be the benchmark by which all other medical RO systems will be compared to."
About Mar Cor Purification
Mar Cor Purification, a wholly-owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is the largest supplier of dialysis medical water systems in North America. It has service offices in 22 cities in the United States and Canada, with seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Filtration/separation products and disinfectants are provided to the same customer base in addition to a separate worldwide distributor network. Visit our website at
http://www.mcpur.com. The direct link to the product page is http://www.mcpur.com/main/biopurehx2.html.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.
SOURCE:
Mar Cor Purification
Contact information:
Christopher Fournier
cfournier@mcpur.com
Vice President Marketing
Mar Cor Purification
Phone: 978-453-9600
Mar Cor Purification
14550 28th Avenue
North Plymouth, MN. 55447
Tel: (484) 991-0220
Fax: (763) 210-3868
www.mcpur.com
